A Guide to Pharmaceutical Particulate Science
1574911422
9781574911428
Description:
The pharmaceutical applications of powder technology have long been recognized. Yet while many books focus on aspects of powder formation and behavior, there has been no text that explores the power of particulate science in the design, manufacture, and control of quality medicines. Until now. A Guide to Pharmaceutical Particulate Science discusses key principles of particulate science and their practical applications.
The authors cover particulate material, its form and production, sampling from bodies of powder, particle size descriptors and statistics, behavior of particles, instrumental analysis, particle size measurement and synergy of adopted techniques, physical behavior of a powder, and in vitro and in vivo performance criteria. They draw the components of particulate science into a single concise description of their current and potential uses in product development. Exploring the growth in knowledge of particle properties and the variety of technological advances in particle manufacture, A Guide to Pharmaceutical Particulate Science gives readers the tools they need to grasp the science and its use in the industry.
Best prices to buy, sell, or rent ISBN 9781574911428
Frequently Asked Questions about A Guide to Pharmaceutical Particulate Science
The price for the book starts from $202.62 on Amazon and is available from 14 sellers at the moment.
If you’re interested in selling back the A Guide to Pharmaceutical Particulate Science book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the A Guide to Pharmaceutical Particulate Science book, the best buyback offer comes from and is $ for the book in good condition.
The A Guide to Pharmaceutical Particulate Science book is in very low demand now as the rank for the book is 11,659,400 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.